Building Clinical Decision Support Tools: What Engineering Teams Should Know

The FDA Line You Don't Want to Cross by Accident

The FDA has a specific, structured framework for Software as a Medical Device, and a surprising number of clinical decision support tools cross into it without anyone on the engineering team realizing it happened. Broadly, CDS software that provides recommendations a clinician can independently evaluate and that displays the underlying evidence stays outside SaMD regulation; software that generates a specific patient-management directive without exposing the basis for it, or that's designed to be the primary basis for a clinical decision rather than a supporting input, likely falls inside it. That distinction has to inform the product design from the first wireframe — whether the tool shows its reasoning or just an output changes which regulatory category the finished product lives in.

Alert Fatigue Is a Design Failure, Not a Clinician Problem

Alert fatigue is the single biggest reason clinical decision support tools get ignored or actively worked around by the clinicians they're meant to help, and it's fundamentally an engineering and design failure, not a training problem to fix with a memo. A CDS tool that fires a moderate-severity drug interaction alert on every prescription, regardless of clinical context, teaches clinicians to click through alerts reflexively within weeks, at which point the tool has stopped functioning entirely, including for the rare alert that actually mattered. Tuning alert thresholds against real clinical context, and suppressing low-value alerts aggressively, is not a nice-to-have refinement; it's the difference between a tool that gets used and one that gets muted. Getting this wrong isn't just a compliance risk, it changes the entire go-to-market timeline, since a tool that unexpectedly requires FDA clearance needs a validation study and a submission process that a purely advisory tool never has to budget for.

Explainability Isn't Optional When a Recommendation Touches Care

A recommendation engine that says "consider this medication" without showing why is asking a clinician to either blindly trust a black box or ignore it, and neither outcome is acceptable in a clinical setting. Every CDS recommendation we build surfaces the specific data points that drove it — the lab values, the medication history entries, the risk factors — so a clinician can evaluate the reasoning against their own judgment rather than accepting or rejecting an opaque output. This isn't just good UX; it's what keeps the tool in the "supporting a clinician's decision" category rather than "making the decision," which matters both for regulatory classification and for actual clinical trust.

Integrating With the EHR Is Harder Than the API Docs Suggest

Every EHR integration proposal reads simply on paper — "we'll pull data via FHIR" — and then meets the reality that FHIR implementations vary meaningfully between EHR vendors, that historical data often predates FHIR adoption and lives in HL7 v2 feeds with inconsistent field usage, and that a hospital's specific EHR configuration frequently diverges from the vendor's default in ways nobody documented. Budget real engineering time for data mapping and validation against a specific institution's actual data, not the specification's ideal case, and expect the first month of any serious clinical integration to be mostly data quality work rather than feature work.

Versioning Clinical Logic Like You'd Version a Financial Model

Clinical decision logic changes as guidelines update, and a CDS tool needs to version that logic with the same discipline a fintech team applies to a pricing or risk model, because when a clinician asks "why did the tool recommend this in March," you need to reproduce exactly the ruleset that was active at that moment, not the current one. We version every clinical rule set explicitly, tie every historical recommendation to the rule version that generated it, and require a documented review and sign-off process before a new rule version goes live. Treating clinical logic as code that ships silently on a normal deploy cadence is how a tool ends up making an outdated recommendation nobody can trace back to its source.

A clinical decision support tool that can't explain itself isn't supporting a decision, it's asking a clinician to make a leap of faith.

Human-in-the-Loop Is a Design Constraint, Not a Cop-Out

Building genuine human-in-the-loop design into a CDS tool means the architecture actively prevents the tool from becoming the sole basis for a clinical action — no auto-executed orders based on a recommendation, no interface pattern that makes accepting the suggestion the path of least resistance compared to reviewing it. This is a real design constraint that shapes interaction patterns, not a legal disclaimer added to satisfy a compliance review. Engineering teams building clinical decision support software should treat "how easy is it for a clinician to override or ignore this" as a metric worth designing for deliberately, not an edge case to handle later.

For more on how we build in this space, see our HealthTech development work.